ATPC (Agape ATP) Utang jangka cendhak marang modal

Logo korporat perusahaan Agape ATP Corp (ATPC)

Agape ATP Corporation (ATPC) enjoys high consumer trust within the Asian wellness programs segment. The market capitalization trend on the GURU.Markets platform, which currently stands at 0.00, reflects the dynamics of a company striving for dominance in metabolic pharma through digital wellness services. Business growth is driven by the development of personalized medicine and the demand for dietary supplements in Southeast Asia.

Rasio tanggungan utang jangka cendhak marang modal: agapeatpgroup.com (ATPC) kanggo 21.02.2024 - 31.10.2026
Produk merek agapeatpgroup.com

This ratio is calculated as the proportion of liabilities maturing within one year to equity, determining the operational dependence on short-term borrowing. For Agape ATP Corporation (ATPC), which leverages high loyalty among Asian dietary supplement consumers, the current short-term debt-to-equity level reflects a balance between financial stability and the pace of the brand's expansion within the longevity market.

Pesaing Agape ATP Corporation

Utang jangka cendhak marang modal ASND|MDGL (Madrigal Corp) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal CORT (Corcept Therapeutics)|Utang jangka cendhak marang modal rhythmtx.com RYTM|AKRO - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal MTSR (Metsera, Inc.)|MoonLake Pharma (MLTX) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Crinetics Corp|NAMS (NewAmsterdam Pharma) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal soleno.life|Rasio utang jangka cendhak marang ekuitas FOLD (Amicus Therapeutics, Inc.)|ETNB (89bio Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Agios Pharmaceuticals Inc AGIO|GPCR - Rasio utang jangka cendhak marang ekuitas|MiMedx Group, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal rezolutebio.com|LXRX (Lexicon Pharmaceuticals, Inc.) - Rasio utang jangka cendhak marang ekuitas|MBX: Rasio silihan jangka cendhak marang modal|ALT (Altimmune Corp) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Aardvark Pharma|Utang jangka cendhak marang modal SGMT|Utang jangka cendhak marang ekuitas BIOA (bioagelabs.com)|Utang jangka cendhak marang ekuitas Biomea Fusion BMEA|Quince Therapeutics Inc (QNCX) - Kewajiban jangka cendhak marang modal|GUTS - Utang jangka cendhak marang ekuitas|VTVT: Utang jangka cendhak marang ekuitas|PLUR: Utang jangka cendhak marang modal|SYBX - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Lipocine|Matinas BioPharma Holdings Inc. (MTNB) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Spruce Biosciences (SPRB)|Rasio utang jangka cendhak marang ekuitas Galecto Corporation GLTO|Utang jangka cendhak marang modal CTCX (Carmell Corporation)|Utang jangka cendhak marang modal lumos-pharma.com LUMO|Organovo - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Radius Recycling Inc. (RDUS)